Updated On: 05 January, 2021 12:00 AM IST | New Delhi | IANS
"Both companies respect the great work being carried out by each other and put behind us the miscommunication and misunderstanding caused during the past week," they said in a joint statement.

Photo for representational purpose
In a show of solidarity after some bitter comments, Adar Poonawala and Krishna Ella, jointly on behalf of Serum Institute and Bharat Biotech, on Tuesday communicated their combined intent to develop manufacture and supply the COVID-19 vaccines for India and globally.
"Both companies respect the great work being carried out by each other and put behind us the miscommunication and misunderstanding caused during the past week. We are fully aware of the importance of vaccines for people and countries alike, we hereby communicate our joint pledge to provide global access for our Covid-19 vaccines," they said in a joint statement. There had been some allegations by Bharat Biotech on Monday blaming Serum Institute and the quality of trials.